Circles on off white ground.
© [M] Munich Re [1] Shutterstock / Derexhopz

Life Science Report 2025

Turning evidence into excellence

    alt txt

    properties.trackTitle

    properties.trackSubtitle

    Medical breakthroughs and cutting-edge technological advances are shaping the life and health insurance industry. With the potential to change mortality and morbidity, life and health insurers need to understand the underlying biometric risks and business implications.

    A business guide on emerging medical trends and risks

    Munich Re's Life Science Report provides a comprehensive guide to assessing both the promises and pitfalls of emerging medical trends and risks, helping life and health insurers to better navigate this environment of changing mortality and morbidity. In five tailored editions released in the first quarter of 2025, the report examines the topics of Artificial Intelligence in Healthcare, Improving Cancer Outcomes, Prevention, Obesity and Climate Change.

    Our global medical team provides comprehensive analysis and expert perspectives throughout the five editions, including in-depth reviews of biomedical advances, guidance on affected risk factors and product lines, and actionable imperatives to capitalize on these advances while mitigating risks.

    Watch our experts introduce the Life Science Report 2025

    Introducing regional services and solutions

    In addition to providing the latest medical insights and their business implications, each edition of the report is complemented by an overview of Munich Re’s regionally tailored services and solutions that enable life and health insurers to anticipate and respond to these emerging trends and risks.

    The Life Science Report 2025 will help you turn medical evidence into business excellence.

    Explore the current and upcoming editions

    Subscribe to newsletter for other topics

    Stay tuned for the other topics in our Life Science Report 2025. Over five editions published in the first quarter of 2025, our global medical team will explore key trends and risks that have the potential to reshape the mortality and morbidity landscape: 

    • Artificial Intelligence in Healthcare,
    • Improving Cancer Outcomes,
    • Prevention,
    • Obesity,
    • Climate Change. 

    The report provides life and health insurers an actionable guide to prepare for the underlying business implications. Sign up for email updates on upcoming editions. Please note that we will contact you once to ask for your consent for further communication according to our privacy policy

    Please enter a value. This selection is mandatory.
    Please enter a value.
    Please enter a value.
    Please enter your e-mail address.
    Thank you for your message. Your message has been sent to our Life Science Report team.
    Something went wrong please try again!

    Contact our experts

    Gina Guzman
    Dr. Gina Guzman
    Vice President & Chief Medical Director
    Munich Re Life US
    Timothy Meagher
    Dr. Tim Meagher
    Vice President & Medical Director
    Munich Re, Canada (Life)
    Bradley Heltemes
    Dr. Bradley Heltemes
    Vice President & Medical Director of R&D
    Munich Re Life US
    Alban Senn
    Dr. Alban Senn
    Chief Medical Officer, Head of Medical Research & Development
    Munich Re Life & Health
    Europe & Latin America
    Javier Gracia San Román
    Dr. Javier Gracia San Román
    Chief Medical Officer
    Munich Re Life & Health
    Southern Europe & Latin America
    Mathias Orban
    Prof. Dr. Mathias Orban
    Senior Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Christiane Suchy
    Dr. Christiane Suchy
    Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Andreas Armuss
    Dr. Andreas Armuss
    Chief Medical Officer
    Munich Re Life & Health
    Asia-Pacific, Middle East & Africa
    Matthew Paul
    Dr. Matthew Paul
    Chief Medical Officer
    Munich Re Life & Health
    Australia & New Zealand
    Hao Liu
    Dr. Hao Liu
    Chief Medical Proposition Officer
    Munich Re Life & Health
    Asia-Pacific
    Jaee Menon
    Dr. Jaee Menon
    Chief Medical Consultant
    Munich Re Life & Health
    South Asia, Southeast Asia, GCC